pX330_HR_Prnp_3 Citations (4)

Originally described in: Manipulating the Prion Protein Gene Sequence and Expression Levels with CRISPR/Cas9.
Kaczmarczyk L, Mende Y, Zevnik B, Jackson WS PLoS One. 2016 Apr 29;11(4):e0154604. doi: 10.1371/journal.pone.0154604. eCollection 2016. PubMed Journal

---

Articles Citing pX330_HR_Prnp_3

Articles
CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity. Walton JB, Farquharson M, Mason S, Port J, Kruspig B, Dowson S, Stevenson D, Murphy D, Matzuk M, Kim J, Coffelt S, Blyth K, McNeish IA. Sci Rep. 2017 Dec 4;7(1):16827. doi: 10.1038/s41598-017-17119-1. PubMed
SNX14 mutations affect endoplasmic reticulum-associated neutral lipid metabolism in autosomal recessive spinocerebellar ataxia 20. Bryant D, Liu Y, Datta S, Hariri H, Seda M, Anderson G, Peskett E, Demetriou C, Sousa S, Jenkins D, Clayton P, Bitner-Glindzicz M, Moore GE, Henne WM, Stanier P. Hum Mol Genet. 2018 Jun 1;27(11):1927-1940. doi: 10.1093/hmg/ddy101. PubMed
Heterozygosity for cervid S138N polymorphism results in subclinical CWD in gene-targeted mice and progressive inhibition of prion conversion. Arifin MI, Kaczmarczyk L, Zeng D, Hannaoui S, Lee C, Chang SC, Mitchell G, McKenzie D, Beekes M, Jackson W, Gilch S. Proc Natl Acad Sci U S A. 2023 Apr 11;120(15):e2221060120. doi: 10.1073/pnas.2221060120. Epub 2023 Apr 4. PubMed
Anti-prion drugs do not improve survival in knock-in models of inherited prion disease. Walsh DJ, Rees JR, Mehra S, Bourkas MEC, Kaczmarczyk L, Stuart E, Jackson WS, Watts JC, Supattapone S. bioRxiv [Preprint]. 2023 Sep 29:2023.09.28.559951. doi: 10.1101/2023.09.28.559951. PubMed

If you have published an article using this material, please email us at to have your article added to this page.